(79 days)
No
The description focuses on standard control systems (thermoregulation, oxygen control) using sensors and a microprocessor, without mentioning AI or ML algorithms for decision-making or pattern recognition.
Yes.
The device functions as an infant incubator and warmer, providing thermal support and controlled oxygen delivery to neonates who are unable to regulate their own body temperature and require specific oxygen concentrations, thus directly treating a physiological condition.
No
Explanation: The device is an infant incubator and warmer that provides thermal support and controlled oxygen delivery. Its function is therapeutic and supportive, not diagnostic, as it does not detect, diagnose, monitor, or treat diseases or conditions by providing information about the patient's health status.
No
The device description clearly details physical components like an infant bed, heating elements (circulating heated air, infrared heat source), sensors (fuel cell type), valves, and a microprocessor controlling these hardware elements. While software is mentioned for validation, the core functionality and description are centered around a physical medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The OmniBed is a medical device that provides thermal support (heating) and potentially oxygen to neonates. It directly interacts with the patient's external environment and body temperature, not with samples taken from the body for analysis.
- Intended Use: The intended use describes providing controlled heat and oxygen to neonates who cannot regulate their own temperature. This is a therapeutic and supportive function, not a diagnostic one.
- Device Description: The description details the mechanical and operational aspects of the incubator and warmer modes, including air circulation, radiant heat, and oxygen delivery. There is no mention of analyzing biological samples.
- Lack of IVD Indicators: The text does not mention any of the typical components or processes associated with IVDs, such as reagents, assays, sample collection, or analysis of biological markers.
Therefore, the OmniBed falls under the category of a therapeutic or supportive medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The OmniBed is a combination of an infant incubator and an infant warmer. The device can be operated as an incubator or as a warmer and can transition from one mode to ther on user's demand. It cannot be operated in both modes at the same time.
Incubators and warmers provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Incubators provide an enclosed, temperatures controlled environment and warmers provide infrared heat in an open environment. They may also be used for short periods of time to facilitate the neonate's transition from the uternal environment. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).
Product codes
FMZ, FMT
Device Description
The Ohmeda Medical Giraffe OmniBed is an infant bed which provides thermal support for infants who are unable to provide for their own heat requirements. This bed has two modes of operation, enclosed bed operation and open bed operation.
In the enclosed bed mode of operation, the bed functions as an incubator, maintaining the infant's temperature by circulating heated air within the enclosed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. In the enclosed bed mode, humidity and oxygen may also be increased.
In the open bed mode, this bed operates like a convention open, radiantly heated infant bed. Radiant heat from an infrared heat source is focused on to the bed to warm the patient. The operator may select either the heater power or skin temperature control method. Depending on the control method selected, the heater is either regulated at the operator selected power level or the heater output is modulated to maintain the patient's temperature at the value selected by the operator.
The optional Giraffe Servo Controlled Oxygen System is a fully integrated option available on the Giraffe OmniBed. The Servo Controlled Oxygen System is capable of oxygenating the entire infant compartment at oxygen concentrations of 21-65% by volume. The device uses fuel cell type sensors that generate specific voltages depending on the oxygen concentrations they contact. The microprocessor stores the sensor output and compares it with the value corresponding to the concentration set by the operator. The valves that supply oxygen to the infant compartment are opened and closed as necessary to maintain the oxygen concentration at the set value. Fluctuations in fuel cell performance due to temperature and humidity are compensated for by the microprocessor.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
neonates
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Since care of newborns in incubators and infant radiant warmers, with or without supplemental oxygen is a well established clinical practice. Ohmeda submits that clinical or animal testing to demonstrate safety and effectiveness is not necessary. The product was subject to extensive bench testing, the software was validated, and, to the best of Ohmeda Medical's knowledge, the requirements of 21 CFR 820, Subpart C -Design Controls - were satisfied.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).
0
MAY 0 9 2002
Ohmeda Medical Giraffe® OmniBed™ 510(k) Summary
Submitter Information
Alberto F. Profumo, RAC 8880 Gorman Road Laurel, MD 21046-1801 Tel. (410) 888-5104 Summary prepared on 2/12/2002
Device Name(s)
Classification Name:
-
Neonatal Incubator .
Common Name: -
Incubator .
Proprietary Name: -
Ohmeda Medical Giraffe" OmniBed with Optional Servo Control Oxygen System .
Predicate Device Information
The Giraffe OmniBed is substantially equivalent to the following Class II devices:
| Device | Last 510(k)
Number |
|-------------------------------------------|-----------------------|
| Ohmeda Medical Giraffe OmniBed (original) | K993407 |
| Drager Incubator 8000 IC | K954204 |
| Isolette Infant Incubator Model C2HS | K001242 |
Product Description
The Ohmeda Medical Giraffe OmniBed is an infant bed which provides thermal support for infants who are unable to provide for their own heat requirements. This bed has two modes of operation, enclosed bed operation and open bed operation.
In the enclosed bed mode of operation, the bed functions as an incubator, maintaining the infant's temperature by circulating heated air within the enclosed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. In the enclosed bed mode, humidity and oxygen may also be increased.
1
In the open bed mode, this bed operates like a convention open, radiantly heated infant bed. Radiant heat from an infrared heat source is focused on to the bed to warm the patient. The operator may select either the heater power or skin temperature control method. Depending on the control method selected, the heater is either regulated at the operator selected power level or the heater output is modulated to maintain the patient's temperature at the value selected by the operator.
The optional Giraffe Servo Controlled Oxygen System is a fully integrated option available on the Giraffe OmniBed. The Servo Controlled Oxygen System is capable of oxygenating the entire infant compartment at oxygen concentrations of 21-65% by volume. The device uses fuel cell type sensors that generate specific voltages depending on the oxygen concentrations they contact. The microprocessor stores the sensor output and compares it with the value corresponding to the concentration set by the operator. The valves that supply oxygen to the infant compartment are opened and closed as necessary to maintain the oxygen concentration at the set value. Fluctuations in fuel cell performance due to temperature and humidity are compensated for by the microprocessor.
Indications for Use
The OmniBed is a combination of an infant incubator and an infant warmer. The device can be operated as an incubator or as a warmer and can transition from one mode to ther on user's demand. It cannot be operated in both modes at the same time.
Incubators and warmers provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Incubators provide an enclosed, temperatures controlled environment and warmers provide infrared heat in an open environment. They may also be used for short periods of time to facilitate the neonate's transition from the uternal environment. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).
Assessment of Technological Characteristics
The technological characteristics of the Giraffe Incubator are similar to those of predicate devices and do not raise new safety or effectiveness issues.
Performance Data
Since care of newborns in incubators and infant radiant warmers, with or without supplemental oxygen is a well established clinical practice. Ohmeda submits that clinical or animal testing to demonstrate safety and effectiveness is not necessary. The product was subject to extensive bench testing, the software was validated, and, to the best of Ohmeda Medical's knowledge, the requirements of 21 CFR 820, Subpart C -Design Controls - were satisfied.
Sterilization Information
The Giraffe" Incubator is not intended to be sterilized. Cleaning and disinfection instructions can be found in the Operations and Maintenance Manual.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an emblem with three stylized wavy lines.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 0 9 2002
Mr. Alberto F. Profumo Director, Product Assurance Ohmeda Medical 8880 Gorman Road Laural . Maryland 20723
Re: K020543
Trade/Device Name: Ohmeda Medical Giraffe OmniBed Regulation Number: 880.5400 Regulation Name: Neonatal Incubator Regulatory Class: II Product Code: FMZ and FMT Dated: February 11, 2002 Received: February 19, 2002
Dear Mr. Profumo:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
3
Page 2 - Mr. Alberto F. Profumo
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618 . Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Runne
Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known): 11020543
Device Name: Ohmeda Medical OmniBed
Indications for Use:
The OmniBed is a combination of an infant incubator and an infant warmer. The device can be operated as an incubator or as a warmer and can transition from one mode to ther on user's demand. It cannot be operated in both modes at the same time.
Incubators and warmers provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Incubators provide an enclosed, temperatures controlled environment and warmers provide infrared heat in an open environment. They may also be used for short periods of time to facilitate the neonate's transition from the uterus to the external environment. This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide a stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).
Patrice Cucenbe
(Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devic 510(k) Number _
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CDR 801.109)
OR
Over-The Counter Use (Optional Format 1-2-96)